Avacta Group (LON:AVCT) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened

Shares of Avacta Group Plc (LON:AVCT) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 43.97 ($0.58) and traded as low as GBX 32.50 ($0.43). Avacta Group shares last traded at GBX 32.75 ($0.44), with a volume of 1,419,363 shares.

Avacta Group Trading Down 2.2 %

The company has a debt-to-equity ratio of 52.53, a current ratio of 1.29 and a quick ratio of 4.96. The stock has a market capitalization of £124.42 million, a price-to-earnings ratio of -4.21 and a beta of 1.12. The business has a 50 day simple moving average of GBX 36.57 and a 200-day simple moving average of GBX 43.97.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).